What Researchers Did
Researchers described how hyperbaric oxygen therapy (HBOT) centers adapted their operations, including session timing, decontamination, and telehealth use, during the COVID-19 pandemic.
What They Found
They found that many outpatient wound and hyperbaric oxygen therapy (HBOT) centers faced closures or limited hours due to the pandemic's financial and infectious disease impacts. Centers adapted by modifying HBOT session timing, enhancing chamber decontamination, and utilizing telehealth for initial patient evaluations. Additionally, they noted that while COVID-19 is not an accepted HBOT indication, facilities should be aware of its potential use for post-infectious sequelae.
What This Means for Canadian Patients
Canadian patients requiring hyperbaric oxygen therapy (HBOT) during the pandemic likely experienced similar adaptations in service delivery to ensure continued access to essential care. This study highlights the importance of HBOT centers being prepared to manage evolving healthcare needs, including potential post-COVID-19 complications.
Canadian Relevance
This study has no direct Canadian connection as it focuses on healthcare shifts and adaptations within the United States.
Study Limitations
A limitation of this descriptive paper is the absence of empirical data or a formal evaluation of the effectiveness of the described adaptations.